杭州启明医疗器械股份有限公司 VENUS MEDTECH (HANGZHOU) INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion 2025-11-17 17:00
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement 2025-10-25 15:00
Court Sides with Cardiovalve in Edwards patent spat 2025-08-05 20:00
Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations 2025-04-22 09:00
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study 2024-09-05 16:56
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. 2024-06-14 15:15
Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval 2024-02-05 21:00
Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023 2023-11-20 07:09
VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally 2023-08-07 08:20
Confirmatory clinical trial of Liwen RF™ ablation system in China concluded 2023-03-06 07:29
Venus Medtech to showcase its structural heart treatments at London Valves 2022 2022-11-25 18:08
Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence 2022-09-01 20:55
Filling gap in market: VenusP-Valve™ approved by China's NMPA 2022-07-13 20:26
First American Patient Treated with VenusP-Valve™ Under Compassionate Use 2022-06-22 18:02
VenusP-Valve(TM) obtains CE marking under MDR and debuts in Europe as China's first valve product 2022-04-12 09:20
Venus Medtech announces 2021 annual results: pacesetter in China and breakthrough-maker worldwide 2022-04-01 10:34
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system 2022-03-18 20:02
Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve 2022-01-26 14:28
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement 2021-12-08 08:28
Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System 2021-07-28 11:41
1 2